ERBB3 and intrahepatic cholangiocarcinoma: ERBB3 was markedly upregulated in 10% (1/10) of patients with GBC, 23% (6/23) of patients with ICC, and 17% (3/18) of those with ECC, respectively, and was mainly overexpressed in the cytoplasm [27].